Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLiabilities from Discontinued OperationsLong-Term InvestmentsNon-Current AssetsNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Standard Biotools (LAB) Finished Goods (2016 - 2025)

Historic Finished Goods for Standard Biotools (LAB) over the last 16 years, with Q3 2025 value amounting to $12.7 million.

  • Standard Biotools' Finished Goods rose 3961.68% to $12.7 million in Q3 2025 from the same period last year, while for Sep 2025 it was $12.7 million, marking a year-over-year increase of 3961.68%. This contributed to the annual value of $7.3 million for FY2024, which is 1049.19% down from last year.
  • Latest data reveals that Standard Biotools reported Finished Goods of $12.7 million as of Q3 2025, which was up 3961.68% from $13.9 million recorded in Q2 2025.
  • Over the past 5 years, Standard Biotools' Finished Goods peaked at $15.2 million during Q4 2022, and registered a low of $7.3 million during Q4 2024.
  • Its 5-year average for Finished Goods is $11.1 million, with a median of $11.0 million in 2021.
  • Per our database at Business Quant, Standard Biotools' Finished Goods surged by 6020.56% in 2021 and then tumbled by 4679.57% in 2023.
  • Standard Biotools' Finished Goods (Quarter) stood at $10.6 million in 2021, then skyrocketed by 43.64% to $15.2 million in 2022, then plummeted by 46.8% to $8.1 million in 2023, then decreased by 10.49% to $7.3 million in 2024, then surged by 74.66% to $12.7 million in 2025.
  • Its Finished Goods stands at $12.7 million for Q3 2025, versus $13.9 million for Q2 2025 and $11.6 million for Q1 2025.